Stable Upconversion Nanohybrid Particles for Specific Prostate Cancer Cell Immunodetection.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Prostate cancer is a leading cause of death in men, with early detection crucial for effective treatment and reduced costs.
• Detecting early-stage prostate cancer is challenging due to the low number of cancer cells present.
• Existing detection methods may lack the sensitivity or specificity required for early-stage diagnosis.

Purpose of the Study:

• To design and develop upconversion immune-nanohybrids (UINBs) for highly sensitive and specific early-stage prostate cancer cell detection.
• To create nanohybrids with sustainable stability in physiological conditions and stable optical properties.
• To demonstrate a versatile strategy for developing UCNP-based nanohybrids for sensitive disease detection.

Main Methods:

• Characterization of UINBs using transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), dynamic light scattering (DLS), and luminescence spectroscopy.
• Confirmation of targeting function using immunofluorescence assay and western blot analysis.
• Evaluation of UINB system for specific detection of prostate cancer cells.

Main Results:

• Successfully designed and developed UINBs with sustainable stability and stable optical properties.
• Demonstrated highly specific targeting capability for early-stage prostate cancer cells.
• Achieved stable, background-free luminescent signals for sensitive cancer cell detection.

Conclusions:

• The developed UINBs provide a sensitive and specific method for early-stage prostate cancer detection.
• This work presents a versatile strategy for creating UCNP-based nanohybrids for detecting diseased cells.
• UINBs offer a promising tool for improving early cancer diagnostics.